Project Details
| Status | Active |
|---|---|
| Effective start/end date | 11/1/15 → 8/31/50 |
Funding
- Sarepta Therapeutics, Inc.
4045-101: A Randomized, Double Blind, Placebo Controlled, Dose Titration, Safety,Tolerability, and Pharmacokinetics Study Followed by an Open Label Safety and EfficacyEvaluation of SRP 4045 in Advanced Stage Patients with Duchenne Muscular Dyst
- Kuntz, Nancy L (PD/PI)
Project: Research project